Colgate-Palmolive (CL) Stock Forecast & Price Target

$99.40

+2.91 (+3.02%)

(As of 07/26/2024 ET)

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 18 Analyst Ratings

Based on 18 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 18 analysts, 5 have given a hold rating, and 13 have given a buy rating for CL.

Consensus Price Target

$98.58
-0.83% Downside

High Forecast	$112.00
Average Forecast	$98.58
Low Forecast	$76.00

According to the 18 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $98.58. The highest price target for CL is $112.00, while the lowest price target for CL is $76.00. The average price target represents a forecasted downside of -0.83% from the current price of $99.40.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	13 Buy rating(s)	14 Buy rating(s)	12 Buy rating(s)	7 Buy rating(s)
Hold	5 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$98.58	$93.83	$89.50	$84.75
Forecasted Upside	-0.83% Downside	9.19% Upside	10.33% Upside	12.64% Upside

Get Colgate-Palmolive Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter.

Ad MarketBeat

We just added a $300 account credit to your MarketBeat subscription

MarketBeat All Access is our complete suite of portfolio monitoring software, research tools, stock screeners, proprietary reports, and more. Upgrade today and get $300 off your 2024-2025 subscription. Free for 30 days.

Start Your Risk-Free Trial Here

CL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Colgate-Palmolive Stock vs. The Competition

Type	Colgate-Palmolive	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.72	2.44	2.50
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	-0.83% Downside	695.80% Upside	9.10% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/26/2024	HSBC 2 of 5 stars		Reiterated Rating	Buy ➝ Hold
7/24/2024	Jefferies Financial Group 2 of 5 stars		Downgrade	Buy ➝ Hold	$103.00 ➝ $95.00	-1.61%
7/23/2024	TD Cowen 4 of 5 stars	R. Moskow Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$110.00	+12.30%
7/22/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$95.00 ➝ $105.00	+7.06%
7/19/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$85.00 ➝ $91.00	-7.24%
7/18/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$100.00 ➝ $106.00	+6.91%
Get the Latest News and Ratings for CL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors with MarketBeat's FREE daily newsletter.
7/17/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$98.00 ➝ $104.00	+5.54%
7/10/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$103.00 ➝ $112.00	+15.00%
7/10/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$100.00 ➝ $110.00	+13.26%
7/10/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$92.00 ➝ $97.00	-0.40%
6/24/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Grundy Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$109.00	+12.06%
5/28/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$101.00 ➝ $103.00	+12.20%
5/15/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Graja Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$97.00 ➝ $107.00	+13.01%
4/29/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Sector Perform ➝ Sector Perform	$88.00 ➝ $95.00	+4.38%
3/1/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$93.00	+7.50%
1/29/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$93.00 ➝ $95.00	+13.41%
1/29/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$91.00	+9.86%
1/18/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$88.00 ➝ $90.00	+11.55%
10/12/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$82.00 ➝ $76.00	+10.35%
11/21/2022	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform
10/18/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$88.00 ➝ $85.00	+17.83%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:45 AM ET.

CL Forecast - Frequently Asked Questions

What is Colgate-Palmolive's forecast for 2024?: According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $98.58, with a high forecast of $112.00 and a low forecast of $76.00.
Should I buy or sell Colgate-Palmolive stock right now?: 18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last twelve months. There are currently 5 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CL shares.
Does Colgate-Palmolive's stock price have much upside?: According to analysts, Colgate-Palmolive's stock has a predicted upside of 6.90% based on their 12-month stock forecasts.
Has Colgate-Palmolive been downgraded by Wall Street analysts recently?: Over the previous 90 days, Colgate-Palmolive's stock had 1 downgrade by analysts.
What analysts cover Colgate-Palmolive?: Colgate-Palmolive has been rated by research analysts at Argus, Bank of America, Barclays, BNP Paribas, Citigroup, Deutsche Bank Aktiengesellschaft, Evercore ISI, HSBC, Jefferies Financial Group, Morgan Stanley, Royal Bank of Canada, Stifel Nicolaus, TD Cowen, and Wells Fargo & Company in the past 90 days.
Do Wall Street analysts like Colgate-Palmolive more than its competitors?: Analysts like Colgate-Palmolive more than other "consumer staples" companies. The consensus rating for Colgate-Palmolive is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CL compares to other companies.